Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Patrick Lockwood-Taylor On June 7, 2026, Patrick Lockwood-Taylor resigned, effective immediately, as President and Chief Executive Officer and as a member of the Board of Directors (the “Board”) of Perrigo Company plc (the “Company”).…
Filed Jun 8, 2026Accepted Jun 8, 2026, 4:22 PM EDTCIK 1585364Accession 0001193125-26-261809
Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Patrick Lockwood-Taylor
On June 7, 2026, Patrick Lockwood-Taylor resigned, effective immediately, as President and Chief Executive Officer and as a member of the Board of Directors (the “Board”) of Perrigo Company plc (the “Company”). This resignation follows a determination by the Board that certain personal conduct was not consistent with the Company’s Code of Conduct and core values. Consequently, the Board has reduced the number of directors constituting the Board from 9 to 8.
Mr. Lockwood-Taylor’s resignation is not related to the Company’s business, strategy, operations, financial reporting, or results of operations.
Appointment of Interim President and Chief Executive Officer
On June 7, 2026, the Board appointed Albert A. Manzone, Director and member of the Audit Committee of the Board, as the Company’s Interim President and Chief Executive Officer. Concurrently, the Board has initiated a comprehensive search process to identify a permanent President and Chief Executive Officer.
Mr. Manzone’s biography is set forth under the heading “Election of Directors - About the Nominated Directors” in the Company’s Proxy Statement for the 2026 Annual Meeting of Shareholders, filed with the Securities and Exchange Commission on March 20, 2026, which information is incorporated herein by reference.
In connection with his appointment, Mr. Manzone will step down as a member of the Audit Committee during the time of his service as the Interim President and Chief Executive Officer. In addition, Mr. Manzone will step down as Deputy Chief Executive Officer of Monte-Carlo Society des Bains de Mer.
Compensatory arrangements relating to Mr. Manzone’s service as Interim President and Chief Executive Officer of the Company have not been definitively determined as of the date hereof. The Company will provide disclosure of the material terms of such arrangements on an amendment to this current report on Form 8-K within four business days after they become available.
There are no family relationships between Mr. Manzone and any Company director or executive officer, and no arrangements or understandings between Mr. Manzone and any other person pursuant to which he was selected as an officer. Since January 1, 2025, there have been no transactions, and there are no currently proposed transactions, to which the Company was or is a participant and in which Mr. Manzone had or is to have a direct or indirect material interest that would require disclosure pursuant to Item 404(a) of Regulation S-K.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
The Company’s press release regarding the matter described in Item 5.02 above is attached hereto as Exhibit 99.1.
The information in this Item 7.01, including the exhibit attached hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) d102437dex991.htm
EX-99.1
2
d102437dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Perrigo Announces Leadership Transition
Albert A. Manzone Appointed Interim President and CEO
Patrick Lockwood-Taylor Resigns as President and CEO and as a Member of the Board
DUBLIN, June 8, 2026 - Perrigo Company plc (NYSE: PRGO) (“Perrigo” or the “Company”), a leading provider of Consumer
Self-Care Products, today announced that its Board of Directors has appointed Albert A. Manzone, a member of the Company’s Board, as Interim President and Chief Executive Officer, effective immediately. The Board has initiated a comprehensive
search process to identify a permanent successor.
Patrick Lockwood-Taylor has resigned as President and CEO, and as a member of the Board, effective
immediately. This resignation follows a determination by the Board of Directors that certain personal conduct by Mr. Lockwood-Taylor was not consistent with the Company’s Code of Conduct and core values. The conduct did not involve the
Company’s business, strategy, operations, financial reporting, or results of operations.
Orlando D. Ashford, Chair of Perrigo’s Board of
Directors, said, “Perrigo’s core values are foundational to how we operate…